Millendo Therapeutics Inc
MLND
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.15M
Close$
$31.42
2863.9% upside
Current Fair Value
2863.9% upsideUndervalued by 2863.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.15 Million |
|---|---|
| Enterprise Value | $17.93 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-6.33 |
| Beta | 0.48 |
| Outstanding Shares | 15,223,972 |
Return
| Return on Equity | 3713.03% |
|---|---|
| Return on Assets | -420.14% |
| Return on Invested Capital | -274.73% |
Valuation & Multiples
| P/E Ratio | -0.27 |
|---|---|
| PEG | 0.8 |
| Price to Sales | - |
| Price to Book Ratio | -1.06 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.26 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | -6.94 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Millendo Therapeutics Inc
CEO: Julia Owens